Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Breast Cancer

  Free Subscription


21.06.2021

2 Acta Cytol
4 AJR Am J Roentgenol
4 Ann Surg Oncol
2 BMC Cancer
1 Br J Cancer
1 Breast Cancer
1 Breast Cancer Res
6 Breast Cancer Res Treat
2 Breast J
4 Clin Breast Cancer
1 Clin Cancer Res
1 Eur J Surg Oncol
1 Eur Radiol
2 J Clin Oncol
3 NPJ Breast Cancer
3 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Cytol

  1. JIMENEZ-HEFFERNAN JA, Valdivia-Mazeyra M, Munoz-Hernandez P, Lopez-Elzaurdia C, et al
    Cytologic Features of Lipogranulomatous Reaction in an Axillary Sentinel Lymph Node.
    Acta Cytol. 2021;65:272-275.
    PubMed         Abstract available

  2. AGRAWAL S, Anthony ML, Paul P, Singh D, et al
    Accuracy of Breast Fine-Needle Aspiration Biopsy Using the International Academy of Cytology Yokohama System in Clinico-Radiologically Indeterminate Lesions: Initial Findings Demonstrating Value in Lesions of Low Suspicion of Malignancy.
    Acta Cytol. 2021;65:220-226.
    PubMed         Abstract available


    AJR Am J Roentgenol

  3. KUNJUMMEN J, Rodriguez K, Newell MS, Hanley K, et al
    Management of Lobular Neoplasia Found on Core Needle Biopsy Performed for Calcifications Using Precise Radiologic-Pathologic Correlation.
    AJR Am J Roentgenol. 2021 Apr 14:1-10. doi: 10.2214/AJR.19.22599.
    PubMed         Abstract available

  4. HOGAN MP, Amir T, Sevilimedu V, Sung J, et al
    Contrast-Enhanced Digital Mammography Screening for Intermediate-Risk Women With a History of Lobular Neoplasia.
    AJR Am J Roentgenol. 2021 Mar 31:1-6. doi: 10.2214/AJR.20.23480.
    PubMed         Abstract available

  5. RAZA S
    Management of High-Risk Breast Lesions: Counterpoint-Time for Personalized Surveillance.
    AJR Am J Roentgenol. 2021;216:1434-1435.
    PubMed        

  6. CALHOUN BC
    Management of High-Risk Breast Lesions: Point-Surveillance Is a Change in Practice Preceding Evidence-Based Standardization.
    AJR Am J Roentgenol. 2021;216:1432-1433.
    PubMed        


    Ann Surg Oncol

  7. BUCCI LK, Brunelle CL, Bernstein MC, Shui AM, et al
    Subclinical Lymphedema After Treatment for Breast Cancer: Risk of Progression and Considerations for Early Intervention.
    Ann Surg Oncol. 2021 Jun 11. pii: 10.1245/s10434-021-10173.
    PubMed         Abstract available

  8. FURLAN C, Matheus CN, Jales RM, Derchain SFM, et al
    Longitudinal, Long-Term Comparison of Single- versus Multipoint Upper Limb Circumference Periodical Measurements as a Tool to Predict Persistent Lymphedema in Women Treated Surgically for Breast Cancer: An Optimized Strategy to Early Diagnose Lymphede
    Ann Surg Oncol. 2021 Jun 14. pii: 10.1245/s10434-021-10290.
    PubMed         Abstract available

  9. GOLDBACH MM, Burkbauer L, Bharani T, Williams AD, et al
    Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR+ Breast Cancer-An NCDB Analysis (2004-2016).
    Ann Surg Oncol. 2021 Jun 14. pii: 10.1245/s10434-021-10287.
    PubMed         Abstract available

  10. POSTLEWAIT LM, Teshome M, Adesoye T, DeSnyder SM, et al
    Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer.
    Ann Surg Oncol. 2021 Jun 14. pii: 10.1245/s10434-021-10148.
    PubMed         Abstract available


    BMC Cancer

  11. SUN M, Tang C, Liu J, Jiang W, et al
    Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.
    BMC Cancer. 2021;21:696.
    PubMed         Abstract available

  12. DONG J, Sun Q, Pan Y, Lu N, et al
    Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy.
    BMC Cancer. 2021;21:700.
    PubMed         Abstract available


    Br J Cancer

  13. AZAM S, Eriksson M, Sjolander A, Gabrielson M, et al
    Mammographic microcalcifications and risk of breast cancer.
    Br J Cancer. 2021 Jun 14. pii: 10.1038/s41416-021-01459.
    PubMed         Abstract available


    Breast Cancer

  14. GHOREISHY SM, Aminianfar A, Benisi-Kohansal S, Azadbakht L, et al
    Association between dietary phytochemical index and breast cancer: a case-control study.
    Breast Cancer. 2021 Jun 13. pii: 10.1007/s12282-021-01265.
    PubMed         Abstract available


    Breast Cancer Res

  15. THIES KA, Cole MW, Schafer RE, Spehar JM, et al
    The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer.
    Breast Cancer Res. 2021;23:65.
    PubMed         Abstract available


    Breast Cancer Res Treat

  16. ALMODALLAL Y, Le-Rademacher JG, Cook KD, Yadav S, et al
    Observations with alpelisib in older patients (>/= 65 year of age) with breast cancer in a non-clinical trial setting.
    Breast Cancer Res Treat. 2021 Jun 12. pii: 10.1007/s10549-021-06277.
    PubMed         Abstract available

  17. SKARPING I, Fornvik D, Zackrisson S, Borgquist S, et al
    Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer.
    Breast Cancer Res Treat. 2021 Jun 12. pii: 10.1007/s10549-021-06283.
    PubMed         Abstract available

  18. PUMPALOVA YS, Ayeni OA, Chen WC, O'Neil DS, et al
    Impact of HIV infection on overall survival among women with stage IV breast cancer in South Africa.
    Breast Cancer Res Treat. 2021 Jun 14. pii: 10.1007/s10549-021-06265.
    PubMed         Abstract available

  19. RUGO HS, Pennella EJ, Gopalakrishnan U, Hernandez-Bronchud M, et al
    Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer.
    Breast Cancer Res Treat. 2021 Jun 14. pii: 10.1007/s10549-021-06197.
    PubMed         Abstract available

  20. LIVINGSTON-ROSANOFF D, Trentham-Dietz A, Hampton JM, Newcomb PA, et al
    Does margin width impact breast cancer recurrence rates in women with breast conserving surgery for ductal carcinoma in situ?
    Breast Cancer Res Treat. 2021 Jun 15. pii: 10.1007/s10549-021-06278.
    PubMed         Abstract available

  21. PRIOR L, O'Dwyer R, Farooq AR, Greally M, et al
    Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study.
    Breast Cancer Res Treat. 2021 Jun 14. pii: 10.1007/s10549-021-06263.
    PubMed         Abstract available


    Breast J

  22. MICAILY I, Hackbart H, Butryn M, Abu-Khalaf MM, et al
    Obesity in early onset breast cancer in African American patients.
    Breast J. 2021 Jun 11. doi: 10.1111/tbj.14258.
    PubMed         Abstract available

  23. LANGMAN EL, Kuzmiak CM, Brader R, Thomas SM, et al
    Breast cancer in young women: Imaging and clinical course.
    Breast J. 2021 Jun 13. doi: 10.1111/tbj.14261.
    PubMed         Abstract available


    Clin Breast Cancer

  24. MEMON R, Prieto Granada CN, Harada S, Winokur T, et al
    Discordance Between Immunohistochemistry and In Situ Hybridization to Detect HER2 Overexpression/Gene Amplification in Breast Cancer in the Modern Age: A Single Institution Experience and Pooled Literature Review Study: Discordance between HER2 overex
    Clin Breast Cancer. 2021 May 17. pii: S1526-8209(21)00132.
    PubMed         Abstract available

  25. JI X, Li D, Gao D, Lv X, et al
    Value of Ultrasound-Guided Biopsy in Evaluating Internal Mammary Lymph Node Metastases in Breast Cancer.
    Clin Breast Cancer. 2021 May 6. pii: S1526-8209(21)00116.
    PubMed         Abstract available

  26. WANG M, Liu H, Wu W, Zhao J, et al
    Identification of Differentially Expressed Plasma lncRNAs As Potential Biomarkers for Breast Cancer.
    Clin Breast Cancer. 2021 May 18. pii: S1526-8209(21)00131.
    PubMed         Abstract available

  27. TJOE JA, Heslin K, Perez Moreno AC, Thomas S, et al
    Factors Associated With Breast Cancer Surgery Delay Within a Coordinated Multihospital Community Health System: When Does Surgical Delay Impact Outcome?
    Clin Breast Cancer. 2021 May 3. pii: S1526-8209(21)00090.
    PubMed         Abstract available


    Clin Cancer Res

  28. HE X, Ji J, Dai X, Qdaisat AZ, et al
    Association of cardiovascular disease risk factors with late cardiotoxicity and survival in HER2-positive breast cancer survivors.
    Clin Cancer Res. 2021 Jun 11. pii: 1078-0432.CCR-20-4162.
    PubMed         Abstract available


    Eur J Surg Oncol

  29. MONTAGNA E, Bellerba F, Sangalli C, Gandini S, et al
    Management of breast cancer patients during the peak of the COVID 19 pandemic.
    Eur J Surg Oncol. 2021 May 25. pii: S0748-7983(21)00532.
    PubMed        


    Eur Radiol

  30. COOPER JA, Jenkinson D, Stinton C, Wallis MG, et al
    Optimising breast cancer screening reading: blinding the second reader to the first reader's decisions.
    Eur Radiol. 2021 Jun 12. pii: 10.1007/s00330-021-07965.
    PubMed         Abstract available


    J Clin Oncol

  31. SUEMASU T, Shimomura A, Shimizu C, Hashimoto K, et al
    Regarding the Appropriate Target and Duration of Chemoprevention in Breast Cancer.
    J Clin Oncol. 2021 Jun 14:JCO2101060. doi: 10.1200/JCO.21.01060.
    PubMed        

  32. BEYER KMM, Zhou Y, Laud PW, McGinley EL, et al
    Mortgage Lending Bias and Breast Cancer Survival Among Older Women in the United States.
    J Clin Oncol. 2021 Jun 15:JCO2100112. doi: 10.1200/JCO.21.00112.
    PubMed         Abstract available


    NPJ Breast Cancer

  33. LI N, Lim BWX, Thompson ER, McInerny S, et al
    Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study.
    NPJ Breast Cancer. 2021;7:76.
    PubMed         Abstract available

  34. PAOLETTI C, Regan MM, Niman SM, Dolce EM, et al
    Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients.
    NPJ Breast Cancer. 2021;7:77.
    PubMed         Abstract available

  35. WANG L, Zhang Y, He Y, Li J, et al
    Impact of dose-dense neoadjuvant chemotherapy on pathologic response and survival for HER2-positive breast cancer patients who receive trastuzumab.
    NPJ Breast Cancer. 2021;7:75.
    PubMed         Abstract available


    Radiother Oncol

  36. BOSMA SCJ, Hoogstraat M, van Werkhoven E, de Maaker M, et al
    Corrigendum to "A case-control study to identify molecular risk factors for local recurrence in young breast cancer patients" [Radiother Oncol 156 (2021) 127-135].
    Radiother Oncol. 2021 Jun 10. pii: S0167-8140(21)06177.
    PubMed        

  37. HUANG Z, Shi M, Wang WH, Shen LF, et al
    A novel nomogram for predicting locoregional recurrence risk in breast cancer patients treated with neoadjuvant chemotherapy and mastectomy.
    Radiother Oncol. 2021 Jun 10. pii: S0167-8140(21)06587.
    PubMed         Abstract available

  38. TAN H, Cheung P, Louie AV, Myrehaug S, et al
    Outcomes of extra-cranial stereotactic body radiotherapy for metastatic breast cancer: Treatment indication matters.
    Radiother Oncol. 2021 Jun 10. pii: S0167-8140(21)06584.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: